Menu

News & Insights

  • Clear

Bipartisan AGs Reach $49 Million Settlement over Alleged Price-Fixing in Generic Drugs Market

A bipartisan coalition of 50 states, D.C., and two territories reached settlements with Heritage Pharmaceuticals, Inc. and Apotex Corp. to resolve allegations of price fixing generic drugs in violation of the Sherman Act. As part of complaints filed in 2017 and 2019, the AGs allege that the companies, along with other drug manufacturers and their executives,…

Read More

Connecticut’s $39 Million Award a Bitter Bill for Pharmacy to Swallow

Connecticut AG William Tong obtained a judgment in his favor in his office’s lawsuit against Assured Rx, LLC (“Assured”), which alleged that the pharmacy engaged in a kickback scheme in violation of  state false claims and anti-kickback statutes. According to the AG’s office, the complaint alleged that Assured orchestrated a scheme in which retired state employees…

Read More

Connecticut Continues Streak of Solar Settlements

Connecticut AG William Tong has reached a settlement with Vision Solar, LLC to resolve allegations that the company violated the Connecticut Unfair Trade Practices Act through its marketing, sales, permitting, and installation practices related to residential solar panel systems. In the settlement, Vision Solar is alleged to have unfairly and deceptively engaged in high-pressure sales…

Read More

Multistate Coalition Settles False Claims Allegations with Precision Diagnostics

A multistate coalition of 44 AGs and the U.S. Department of Justice settled with Precision Toxicology, LLC d/b/a Precision Diagnostics, Inc. (Precision) to resolve allegations that it made false claims to multiple federal healthcare programs in violation of state and federal false claims and anti-kickback laws. According to the settlement, Precision allegedly had a policy…

Read More

Enzo Biochem Reaches $4.5M Settlement with CT, NJ, and NY Over 2023 Data Breach

The New York, Connecticut, and New Jersey AGs entered into settlements with biotechnology company Enzo Biochem, Inc. and its subsidiary Enzo Clinical Labs, Inc. (collectively, “Enzo”), to resolve allegations stemming from a 2023 data breach involving the personal information of more than 2.4 million individuals in violation of HIPAA security and notification requirements and the…

Read More